Similarly, genetic variations in the GCKR expression can also regulate glucose metabolism and insulin sensitivity in obesity-associated metabolic disorders including NAFLD and T2DM [5, 6]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.